Innovative Oral Formulations for Anti-Tb Drugs
$1,499,796N01FY2018AINIH
Luna Innovations, Inc., Roanoke VA
Investigators
Abstract
This proposal aims to continue the development of a formulation for TB drugs that is stable under ambient conditions and palatable to children.
View original record on NIH RePORTER →